(Q62024876)

English

THE AP-GELP STUDY: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

The AP-GELP Study: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Phosphodiesterase 4-Inhibitor Apremilast in Female Genital Erosive Lichen Planus (English)

0 references

medical condition

lichen planus

0 references

sponsor

Oslo University Hospital

0 references

start time

January 2019

0 references

end time

June 2020

0 references

number of participants

40

0 references

research intervention

apremilast

0 references

thalidomide

0 references

Phosphodiesterase 4 Inhibitors

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

recruiting

0 references

minimum age

18 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03656666

0 references

(Q62024876)

THE AP-GELP STUDY: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)